Pharmaceutical

Eli Lilly doubles down on Oblique partnership for antibody generation

The two companies have expanded their agreement first inked in 2023, with a second ‘high-value target’ now in the crosshairs.

Aug 25, 2024 - 04:00
Eli Lilly doubles down on Oblique partnership for antibody generation
The two companies have expanded their agreement first inked in 2023, with a second ‘high-value target’ now in the crosshairs.
Read the original article

Tags:

Previous Article

AstraZeneca may pull plug on UK vaccine manufacturing plans

Next Article

Jazz’s cannabidiol therapy flunks in Japanese Phase III trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Say goodbye to the Covid-19 vaccination card. The CDC has stopped printing them

Say goodbye to the Covid-19 vaccination card. The CDC h...

Oct 4, 2023

Scientists, going on a bear hunt, find a potential way to treat deadly blood clots

Scientists, going on a bear hunt, find a potential way ...

Apr 13, 2023

GoodRx hires former tech exec as CEO, Amazon shutters Halo, and Teladoc beats expectations

GoodRx hires former tech exec as CEO, Amazon shutters H...

Apr 27, 2023